Oscar Health's stock faced significant pressure on February 4th after the company released its fourth-quarter and full-year 2024 financial results, which fell short of market expectations. The health insurance provider reported a quarterly revenue of $2.39 billion, missing the estimated $2.47 billion, and a quarterly EPS of -$0.62, which was below the anticipated -$0.58. Despite achieving a 56.5% increase i